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Functional Zonation of the Adult
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The standard model of adrenocortical zonation holds that the three main zones,
glomerulosa, fasciculata, and reticularis each have a distinct function, producing
mineralocorticoids (in fact just aldosterone), glucocorticoids, and androgens respectively.
Moreover, each zone has its specific mechanism of regulation, though ACTH has actions
throughout. Finally, the cells of the cortex originate from a stem cell population in the
outer cortex or capsule, and migrate centripetally, changing their phenotype as they
progress through the zones. Recent progress in understanding the development of the
gland and the distribution of steroidogenic enzymes, trophic hormone receptors, and
other factors suggests that this model needs refinement. Firstly, proliferation can take
place throughout the gland, and although the stem cells are certainly located in the
periphery, zonal replenishment can take place within zones. Perhaps more importantly,
neither the distribution of enzymes nor receptors suggest that the individual zones
are necessarily autonomous in their production of steroid. This is particularly true of
the glomerulosa, which does not seem to have the full suite of enzymes required for
aldosterone biosynthesis. Nor, in the rat anyway, does it express MC2R to account for
the response of aldosterone to ACTH. It is known that in development, recruitment of
stem cells is stimulated by signals from within the glomerulosa. Furthermore, throughout
the cortex local regulatory factors, including cytokines, catecholamines and the tissue
renin-angiotensin system, modify and refine the effects of the systemic trophic factors.
In these and other ways it more and more appears that the functions of the gland should
be viewed as an integrated whole, greater than the sum of its component parts.
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INTRODUCTION—THE STANDARD MODEL
The nature and significance of the zonation of the mammalian adrenal cortex has attracted
considerable interest during the fifteen decades following the first description of its three main
zones, zona glomerulosa, zona fasciculata, and zona reticularis, by Arnold (1866). Later, Gottschau
(1883) was the first to suggest that adrenocortical cells originate in the outer part of the gland, and
migrate centripetally, thus becoming phenotypically glomerulosa, then fasciculata and reticularis
in sequence. Zwemer et al. (1938) illustrated a direct lineage of cortical cells from the connective
tissue capsule. Before the functions of the gland were understood, studies were directed to further
descriptions of adrenocortical morphology and development, in mammals and other vertebrates
(Dostoiewsky, 1886; Rabl, 1891; Wiesel, 1902). By the 1940s it was clear that the adrenal cortex,
as well as the medulla, is crucially involved in the response to stress, and further, that secretions
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of the cortex fell into three functional classes: androgens, and
what Selye and Jensen were the first to call mineralocorticoids
and glucocorticoids (Selye, 1946; Selye and Jensen, 1946).
Coupled with the observable changes in appearance and
abundance of the zones in different physiological situations
it then became apparent that the different zones had
different functions, and androgens, mineralocorticoids, and
glucocorticoids were now thought to be products of the zona
reticularis, zona glomerulosa, and zona fasciculata respectively
(Vines, 1938; Swann, 1940; Chester Jones, 1957; Deane, 1962).
Moreover, their regulation was different, and though the
inner adrenocortical zones, fasciculata and reticularis, were
dependent on an intact pituitary and the secretion of ACTH, the
glomerulosa was not (Chester Jones, 1957; Deane, 1962; Vinson,
2003). Later, the essential role of the renin-angiotensin system in
the regulation of aldosterone was elucidated (Gross, 1958; Laragh
et al., 1960; Carpenter et al., 1961), though other factors, possibly
many, are also involved (Vinson et al., 1992b; Ehrhart-Bornstein
et al., 1998; Mulrow, 1999; Vinson, 2003).
Together, such evidence has led to the development of what
may be thought of as the Standard Model of adrenocortical
zonation:
(i) Adrenocortical cells arise in the outer part of the gland and
migrate centripetally, with changes in phenotype as they
progress from the glomerulosa through the fasciculata to the
reticularis, where they undergo apoptosis.
(ii) Each of the three main differentiated zones secretes a
specific profile of steroid hormones.
(iii) Each of the zones is under separate and independent
regulatory control.
There have, however, always been gaps in interpretation that
have scarcely been addressed. Among these is the challenge of
unraveling the mechanisms underlying the profound changes of
phenotype that the cells undergo during their lifespan. Again,
but less frequently considered, what drives cell migration in
the mature gland? Additionally, and rarely addressed: what
is the significance of the zonal arrangement—what advantage
is conferred by the configuration of the different zones as
concentric shells?
It is the purpose of this review to examine both whether the
Standard Model remains compatible with the literature of the
last few years, and also whether there are now clues to these
additional problems.
WHAT DO WE MEAN BY
ADRENOCORTICAL ZONATION?
It is important to define the terms we use. Zonation is a
descriptive term, which has been applied by different observers
to mean sometimes quite different things. Without a strict,
generally adhered-to definition, it is most appropriate to
go back to the pioneers of the terminology, and follow
their usage. Since the earliest descriptors of adrenocortical
zonation were morphological and topographical, and
these alone were used for 70–80 years, it follows that,
without a contrary formal decision, agreed perhaps by a
caucus of international exponents of the field, zonation
remains defined by cellular morphology and topology alone
(Figures 1, 2).
The names of the three main zones are descriptive of the
arrangement of their cells. Thus, the zona glomerulosa is so called
because the whorls or baskets of cells that compose it somewhat
recall the glomeruli of the kidney (Latin glomus, ball) though this
is more apparent in some species (e.g., the dog) than others (rat,
human). The cells of the zona fasciculata lie in parallel radial
cords, and the name stems originally from the Roman symbol of
office, the fasces or bundle of birch rods (etymologically the same
origin, incidentally, as fascist), cf. the anatomical term fascicle
(bundle of nerves or muscle fibers), while the cords of cells of the
reticularis form a network (Latin: rete). Essentially, the smaller,
more densely staining glomerulosa cells are characterized by
their lamelliform cristae, whereas the larger and paler fasciculata
cells have tubulo-vesicular cristae. The reticularis cells retain
tubulo-vesicular cristae, and are again more densely staining and
smaller than fasciculata cells. Lipid distribution varies with the
state of stimulation, but in general is greater in the inner zones.
These criteria have been reviewed on many occasions (Chester
Jones, 1957; Deane, 1962; Neville and O’Hare, 1981; Vinson et al.,
1992b).
FIGURE 1 | Zonation of the Wistar rat adrenal cortex. The main zones of
the cortex. The arrangement of the concentric bands of cells is representative
of most mammal species, though there is some species variation. In the adult
human gland, the glomerulosa is sparse and confined to discrete islets,
whereas in others, such as the dog, the glomerulosa is much more marked,
with large whorls of cells justifying the comparison with the renal glomerulus.
Additional zones may occur in other species, including the X zone in the
mouse gland, and the fetal zone in the developing and newborn human gland
(See Chester Jones, 1957; Deane, 1962; Neville and O’Hare, 1981; Vinson
et al., 1992b).
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FIGURE 2 | Higher power view of the capsule/glomerulosa/outer
fasciculata view of the rat adrenal cortex. Note that in this tissue from an
∼2 month old animal, the zona intermedia is very sparse. There is a marked
differentiation between the glomerulosa and the fasciculata, emphasizing the
precision with which the signals that determine positioning of the different cell
types must operate (see text).
Thus, zonation is not described by function, nor by the
presence of this or that steroid product, or molecular marker.
As it happens, and as this article will make clear, function
follows morphology/topology only partially. For example, in the
rat adrenal, only outer zona glomerulosa cells express CYP11B2
(see Table 1 for abbreviations) in sodium sufficient animals, and
the inner glomerulosa does not. The non-CYP11B2-containing
glomerulosa region was first called the white or undifferentiated
zone (ZU) (Mitani et al., 1994, 1995), while others have called
it the “zona intermedia” (Engeland and Levay-Young, 1999;
Ulrich-Lai et al., 2006). This is confusing, because the term
zona intermedia was previously applied to a morphologically
distinct flattened cell type, quite different from the glomerulosa,
that is limited to a very few cells at the glomerulosa-fasciculata
border (Cater and Lever, 1954; Chester Jones, 1957; Deane, 1962;
Nussdorfer, 1986). Indeed Cater and Lever (Cater and Lever,
1954) report it as absent from 2 month old rat adrenals, while
it is very marked in older animals. It is sparsely evident in the
illustration in Figure 2. It should be noted that these descriptions
apply to the rat adrenal, and the presence of a discrete ZU in other
species is not clear (see below).
Similarly, others have interpreted, and used, CYP11B2 as
a “highly specific zona glomerulosa marker” (Freedman et al.,
2013). It isn’t, since (as noted above) it is expressed by only a small
population of glomerulosa cells.
In yet another re-writing of the literature on adrenocortical
zonation, some authors appear to define the zona reticularis,
not on the basis of its morphology, but as the site of DHEA
and androstenedione production. Defined in this way, the rat
adrenal, it is claimed, does not contain a zona reticularis
(de Joussineau et al., 2012; Pihlajoki et al., 2015), when
it quite obviously does!—see Figure 1—moreover reticularis
cells have been isolated from rat adrenals, their steroidogenic
potential analyzed, and even shown to produce androstenedione,
albeit in small amounts (Bell et al., 1978, 1979), see also
(Pignatelli et al., 2006).
TABLE 1 | Abbreviations used.
ACTH Adrenocorticotrophic hormone, corticotrophin
AgRP Agouti-related peptide
AKR1B7 Aldo-keto reductase family 1 member B7
AKR1C3 Aldo-keto reductase family 1 member C3, type 5 17β-HSD
ANP Atrial natriuretic peptide
AP-1 Activator protein 1 (c-fos, c-jun heterodimeric transcription
factor)
APCC Aldosterone producing cell clusters
ARNTL Aryl hydrocarbon receptor nuclear translocator-like
protein 1, =BMAL
AsP Adrenal secretory protease
AT1R Angiotensin II type 1 receptor
AZ1 Adrenocortical zonation factor
BMAL basic helix-loop-helix/PER-ARNT-SIM (bHLH/PAS) transcription
factor, = ARNTL, MOP3
BMP Bone morphogenetic protein
3β-HSD 3β-hydroxysteroid dehydrogenase
11β-HSD 11β-hydroxysteroid dehydrogenase
20α-HSD 20α-hydroxysteroid dehydrogenase
18-OH-DOC 18-hydroxydeoxycorticosterone
BrdU Bromodeoxyuridine
c-AMP cyclic adenosine monophosphate
c-fos See AP1
c-jun See AP1
CLOCK Circadian Locomotor Output Cycle Kaput gene
CRF Corticotrophin releasing factor
Cry2 Cryptochrome circadian clock 2 gene
Cyt B5 Cytochrome B5
CYP2D16 Cytochrome P4502D16
CYP11A Cytochrome P450scc(cholesterol side chain cleavage)
CYP11B1 Cytochrome P45011B1(11β-hydroxylase)
CYP11B2 Cytochrome P45011B2 (aldosterone synthase)
CYP17 Cytochrome P45017(17-hydroxylase)
CYP21 Cytochrome P45021(21-hydroxylase)
Dab-2 Disabled homolog-2, = DOC2, C9, p96/p67
DACH-1 Dachshund family transcription factor
DAX1 Dosage sensitive reversal adrenal hypoplasia critical region,
chromosome X, = NrOb1
DHCR24 24 dehydrocholesterol reductase, seladin-1
DHEA Dehydroepiandrosterone
Eph Ephrin receptor
ERK Extracellular signal regulated kinase, = MAPK
bFGF basic Fibroblast growth factor
GATA GATA sequence binding transcription factor
Gli1 Glioblastoma 1
Grx Glutaredoxin
GPCR G protein coupled receptor
IGIF Interferon-γ inducing factor = IL 18 or IL-1γ
IGF Insulin-like growth factor
IL Interleukin
IP3 Inositol trisphosphate
IZA Inner zone antigen, = PGRMC-1, Sigma 2 receptor
Ki67 Antigen K67, = MKI67
(Continued)
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TABLE 1 | Continued
LEF1 Lymphoid enhancer-binding factor 1
LHR Luteinizing hormone receptor
MC2R/MC5R Melanocortin receptor 2/5 (ACTH/ melanotrophin receptors
respectively)
MAPK Mitogen activated protein kinase, =ERK
MnSOD Manganese euperoxide dismutase
MRAP Melanocortin-2-receptor accessory protein
α-MSH α-melanocyte stimulating hormone
Nek2 NMA (never in mitosis gene a) related expressed kinase 2
NGFIB nerve growth factor induced clone B;
NPY Neuropeptide Y
Notch1,2 Notch (Drosophila) homolog 1,2
NOV Nephroblastoma overexpressed, = CCN3
NURR-1 Nur-related factor 1
OAT Organic anion transporter
OATP Organic anion transporter polypeptide
ODC Ornithine decarboxylase
Per Period component of Per/Tim (timeless) heterodimer
Pik3c2g Phosphatidylinositol-4-phosphate 3-kinase C2
domain-containing gamma polypeptide gene
PKC Protein kinase C
Prkar1α Type 1 α-regulatory subunit of cAMP dependent protein kinase
PPARγ Peroxisome proliferator activated receptorγ
Pref1 Preadipocyte factor 1, = dlk1 (delta like homolog 1)
Prx Peroxiredoxin
ROS Reactive oxygen species
R26 YFP Rosa 26 yellow fluorescent protein
Rev-Erbα) Nuclear receptor subfamily 1, group D, member 1, NR1D1
SCN Suprachiasmatic nucleus
SF1 Steroidogenic factor 1 (also AD4BP, NR5A1)
Shh Sonic hedgehog (hedgehog signaling pathway component)
SLC27A2 Solute carrier family 27 (fatty acid transporter), member 2
StAR Steroidogenic acute regulatory protein
SULT2A1 Steroid sulfotransferase
TASK1,3 TWIK-related acid-sensitive K +channels, KCNK3 and 9
(members of family of two-pore domain potassium channels)
TGFβ Transforming growth factor
TNF Tumor necrosis factor
Trx Thioredoxin
TrxR Thioredoxin reductase
TSPAN12 Tetraspanin 12
Ucn3 Urocortin 3
VIP Vasoactive intestinal peptide
Wnt Wingless related integration site
ZU Undifferentiated zone
ORIGIN OF THE ADRENAL CORTEX, CELL
PROLIFERATION, AND MIGRATION
The adrenal cortex originates from a section of the coelomic
epithelium, firstly as part of the SF1-expressing adrenogonadal
primordium, then separating as the adrenal anlage into
approximately its ultimate location, ventrolateral to the dorsal
aorta. At this site, it is invaded by cells from the neural
crest, and eventually becomes encapsulated as the discrete
adrenal gland (Xing et al., 2015). An interplay between the
transcription factors SF1 and Dax1 determines the extent to
which steroidogenic enzymes are induced, and adrenocortical
cells become differentiated: Dax 1, as a co-repressor of SF1,
sustains the pluripotential stem cell-like phenotype (Xing et al.,
2015).
In the established cortex, the central concept that there is
a stem cell population located in the capsule or immediate
subcapsular region (Zwemer et al., 1938; Lombardo and
Cortesini, 1988) has largely been supported by evidence from
several types of experiment that track the fate of labeled cells.
Earlier studies followed labeled cells after the pulse
administration of tritiated thymidine in the rat (Wright,
1971; Wright et al., 1973; Zajicek et al., 1986), latterly BrdU
was used in mice (Chang et al., 2013). These gave broadly
similar results, showing initial labeling in the outer part of
the gland, with centripetal migration and phenotype change
at a rate of 13–20 µm per day in the mouse adrenal (Chang
et al., 2013), reaching the medulla after 104 days from initial
labeling in the rat gland (Zajicek et al., 1986). Others have
used transgenic mice bearing the 21OH/LacZ gene (Morley
et al., 1996) or other constructs (Walczak and Hammer, 2015).
Using 21OH/LacZ transgenic mice gives typical results in that
mice bearing this transgene develop stripes of beta-gal staining
cells in the adrenal extending from the capsule to the medulla,
consistent with the concept of an outer region of proliferation
with subsequent inward migration. It has to be said that the
staining is not consistent with the distribution of 21-hydroxylase
in the normal mouse adrenal, which is present only as a trace
in the glomerulosa, though strongly expressed in the adrenal
inner zones (Chang et al., 2013). Similar radial distribution of
labeled cells has shown such lineages in mice bearing for example
shhgfpcre;R26-YFP cells: shh is highly transcribed in the outer
cortex in the mouse (though only in the ZU in the rat), so this
parallels the results obtained with 21OH/LacZ. A similar cell
lineage is seen in mice with the Gli1-creT2 R26-X label: Gli1 is
normally transcribed in the inner capsule in cells that apparently
represent stem cells. Since the capsular expression of Gli1 is
induced by shh signaling, this suggests what King and co-authors
call a bootstrapping loop, by which the recruitment of new
cortical cells from the capsule is stimulated, and both shh and
Gli1 cells are transformed into other cell types throughout the
cortex (King et al., 2009). In fact this process is reinforced by the
glomerulosa specific Dlk1 (also known as Pref-1), a member of
the Notch family, which is co-expressed with shh in the rat, and,
like shh, also signals to the capsule, inducing Gli-1 transcription
and cortical cell recruitment (Guasti et al., 2013b; Finco et al.,
2015). In mouse adrenals regenerating after dexamethasone
treatment, fasciculata cells were similarly shown to be formed
directly from CYP11B2-Cre-bearing zona glomerulosa cells in
an SF-1 dependent process (Freedman et al., 2013), although the
possibility of an intermediate shh-expressing form does not seem
to be excluded.
There is often some ambiguity in such studies in that although
the Standard Model is supported, alternative lineages are not
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necessarily excluded. Thus, fasciculata cells may be formed in
the mouse adrenal from sources independent of the glomerulosa
(Freedman et al., 2013). That proliferation may occur at various
sites in the gland (Payet et al., 1980; Kirillov and Popova, 1985;
McEwan et al., 1996, 1999) does not of itself counter the view that
the stem cells are capsular or subcapsular. However, there is some
additional complexity revealed by the timed appearance of BrdU
labeled cells following pulse labeling in the mouse adrenal cortex
that suggests there may be variation in the fates of individual cells
(Chang et al., 2013), for example, some cells may be retained
in the glomerulosa. Perhaps this may be expected from the
evidence of the expanded glomerulosa, and CYP11B2 expression,
that results from a low sodium diet or angiotensin II treatment
(McEwan et al., 1996, 1999). In control mice, Ki67 staining
showed proliferation predominantly in the glomerulosa and also
in the outer fasciculata, where it was significantly increased by
a pulse of ACTH. These fasciculata cells also expressed 21-
hydroxylase, whereas the BrdU and Ki67 stained glomerulosa
cells were steroidogenically inert, confirming that proliferation
occurs in differentiated as well as partially differentiated cells
(Chang et al., 2013).
Another example of such ambiguity is found in rats, where the
compensatory hypertrophy following unilateral adrenalectomy
may depend on proliferation in the fasciculata (Engeland
et al., 2005) thus 5 days after enucleation proliferation may
occur in both the glomerulosa and the inner part of the
regenerating fasciculata, and after 10–28 days in the outer
fasciculata (Ennen et al., 2005). Different sources of cells may
also arise in other experimental conditions, for example in the
Prkar1a knockout mouse, there is a strong ACTH-independent
centrifugal expansion of corticosterone secreting cells, apparently
from the X-zone (Sahut-Barnola et al., 2010; de Joussineau et al.,
2012). All these potential sites for proliferation and migration of
cells are indicated in Figure 3.
The assumption that, since adrenocortical cells originate in
the outer part of the gland, and migrate centripetally, apoptosis
is essentially a reticularis event, also requires re-examination,
and it now appears that apoptosis occurs throughout all three
zones in humans (Wolkersdorfer and Bornstein, 1998), and in
the rat (Petrovic-Kosanovic et al., 2013). Like the cortex-wide
proliferation that has been described, this presumably confers
flexible tissue remodeling at all levels in the gland. ACTH inhibits
apoptosis, thus stabilizing cortical structure in vivo (Carsia et al.,
1996; Thomas et al., 2004), and in vitro according to some authors
(Carsia et al., 1996) although not according to others, who
describe ACTH-induced apoptosis in cultured rat cells (Mattos
et al., 2011).
MAINTENANCE OF ZONAL
DIFFERENTIATION
Here zonal differentiation implies the anatomical and functional
features that distinguish the cells of the different zones. As
emphasized above, and will be seen in Table 2, functional
differences are not always definitive, many properties may be
shared. Nevertheless, it is remarkable how the differentiation
between glomerulosa and fasciculata, for example, is maintained
(cf. Figures 1, 2). The selection and maintenance of cellular
phenotype clearly depends on location within the gland. Thus,
the three adrenocortical zones always occupy the same relative
position, glomerulosa outermost, reticularis innermost, adjacent
FIGURE 3 | Schematic showing distribution of melanocortin receptors and steroidogenic enzymes in the outer adrenal cortex of the rat (cf. Figure 1).
This illustrates that cellular interaction appears to be required to explain both the synthesis of aldosterone and its regulation by ACTH, thus requiring modification of
the Standard Model of adrenocortical zonation. Vertical arrows indicate potential origins of proliferation and direction of migration of adrenocortical cells. Although the
stem cell population is usually held to be in the capsular/subcapsular region, evidence for all of these possible sites for subsequent proliferation has been reported,
(see text and Kim and Hammer, 2007; Chang et al., 2013; Freedman et al., 2013).
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TABLE 2 | Characteristics of zonal function in (a) rat (b) mouse, and (c) human adult adrenal glands.
(a) Rat
Factor/Gene Glomerulosa Fasciculata/ Reticularis References
STEROIDOGENESIS
CYP11A +/−? +++ Roskelley and Auersperg, 1990; Halder et al., 1998; Mitani et al., 1999; Guasti
et al., 2013b; but see Engeland and Levay-Young (1999)
CYP11B1 − +++ +/− Ho and Vinson, 1993; Halder et al., 1998; Mitani et al., 1999
CYP11B2 + − Halder et al., 1998; Peters et al., 1998; Mitani et al., 1999
CYP21 +/− +++ Chang et al., 2011, 2013
3β-HSD + +++ Dupont et al., 1991; Engeland and Levay-Young, 1999; Pignatelli et al., 1999
11β-HSD1 − − + Shimojo et al., 1996
11β-HSD2 − ++ ++ Smith et al., 1997; Atanassova and Koeva, 2012
StAR − +++ Peters et al., 1998, 2007
RECEPTORS
ATR1 +++ − − Lehoux et al., 1997
MC2R +/− Inner ZU, +++ +/− Gorrigan et al., 2011
MRAP +/− see text +++ +/−
MRAP2 =/− +/− +/−
MC5R +++ + Griffon et al., 1994; van der Kraan et al., 1998
ZONAL HOMEOSTASIS
Shh +++ − Guasti et al., 2011, 2013b
Pref-1/dlk1 +++ − Halder et al., 1998; Raza et al., 1998; Whitworth and Vinson, 2000
NEUROTRANSMITTER
VIP + − Holzwarth et al., 1987; Bernet et al., 1994
NPY + − Holzwarth et al., 1987; Bernet et al., 1994; Renshaw and Hinson, 2001
Catecholamines + − Holzwarth et al., 1987; Bornstein and Ehrhart-Bornstein, 1992
CYTOKINES
IGIF − +++ ++ Conti et al., 1997
*IL-6 + Judd and MacLeod, 1992
*TNF + Judd and MacLeod, 1995
GROWTH FACTORS
Prorenin + ++ + Ho and Vinson, 1998
bFGF + + Chambaz et al., 1994; Ho and Vinson, 1995, 1997
IGF + +
TGFβ − −
SIGNALING
ANP +++ − Lai et al., 2000
AgRP − +++ +++ Bicknell et al., 2000
Prorenin − + Ho and Vinson, 1998
MAPK:ERK-1, ERK-2 ++ − McNeill et al., 1998; McNeill and Vinson, 2000; Vinson et al., 2000; Guasti et al.,
2013b
SF-1 ++ ++ Raza et al., 1998
Dab2 +++ − Romero et al., 2007
Nek 2b + +++ − de Mendonca et al., 2014
Notch1 +++ ++ +
Notch2 +capsule − −
Notch3 +++ ++ +
DETOXIFICATION
**MnSOD − ++ Raza and Vinson, 2000
CLOCK GENES
PER 1 (?) +++ (reticularis) Fahrenkrug et al., 2008
PER 2 Bmal 1
(Continued)
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TABLE 2 | Continued
Factor/Gene Glomerulosa Fasciculata/ Reticularis References
OTHER
IZA − +++ ++ Barker et al., 1992; Halder et al., 1998; Vendeira et al., 1999; Raza et al., 2001
OAT1 − ++ Beery et al., 2003
Oatp1,2 − ++
Oatp3 ++ −
AsP +++ + Bicknell et al., 2001
EphA2, EphA2, EphA3 ++ − Brennan et al., 2008
Spexin +++ ++ ++ Rucinski et al., 2010
*Release from incubated glomerulosa cells **immunoblotting
(b) Mouse
Factor/Gene Glomerulosa Fasciculata/Reticularis X-Zone References
STEROIDOGENESIS
CYP11B1 − +++ − (?) Mukai et al., 2003; King et al., 2009
CYP11B2 +++ −
20α-HSD − − ++ Hershkovitz et al., 2007
3β-HSD +++ +++ −
CYP21 +/− +++ Chang et al., 2013
RECEPTORS
ATR1 +++ − − Huang et al., 2013
SIGNALING
Shh +++ − King et al., 2009
Dax1 +++ − Kim et al., 2009
Mukai et al., 2002; Scheys et al., 2011
GATA4/GATA6 GATA4
in outer capsule only
+++
β-catenin +++ +/− Tevosian et al., 2015
Pihlajoki et al., 2015
CLOCK GENES
Bmal1, CLOCK, Cry2 +++ ++ Oster et al., 2006
Per1, Per2, Per3,
Rev-Erbα
Pik3c2g − − +++ Pihlajoki et al., 2013
DETOXIFICATION
AKR1B7 −? ++ Aigueperse et al., 2001; Martinez et al., 2001
Grx 1 +/− +++ + Godoy et al., 2011
Grx 2,5 ++ + ++
Prx 1,4,5 + +++ +
Prx 3 + + ++
Trx 1,2 + +++ +
TrxR2 + − +
Other
AZ-1 +++ ++(?) ++(?) Mukai et al., 2003; Bastida et al., 2007; Li et al., 2007
ODC +++ ++ −
(c) Human
Factor/Gene Glomerulosa Fasciculata Reticularis References
STEROIDOGENESIS
CYP11B1 − +++ +++ Nishimoto et al., 2010
CYP11B2 + − −
(Continued)
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TABLE 2 | Continued
Factor/Gene Glomerulosa Fasciculata/ Reticularis References
†CYP11A +++ +++ Rege et al., 2014
CYP17 +++ +++ Nishimoto et al., 2010
CYPB5 + +++ Rainey et al., 2002
SULT2A1 + +++ Rainey and Nakamura, 2008
3β-HSD + +++ +/− Nishimoto et al., 2010; but see Rainey et al. (2002)
†3β-HSD2 +++ + Rege et al., 2014
†AKR1C3 +
ZONAL HOMEOSTASIS
DACH1 + +++ Zhou et al., 2015
BMP4 +++ ++ + Rege et al., 2015
SIGNALING
*†LEF1 +++ +/− Rege et al., 2014
*†NOV +++ +/−
†SLC27A2 + +++
†TSPAN12 + +++
NGFIB +++ ++ Bassett et al., 2004b
Nurr-1 +++ +
PPARγ ++ + Uruno et al., 2011
Ucn3 + + Fukuda et al., 2005
CRF1 +/− ++ ++
CRF2 +/− ++ ++
LHR +/− + Pabon et al., 1996
DETOXIFICATION
Seladin − +++ +++ Battista et al., 2009
†AKR1C3 + +++ Rege et al., 2014
This table lists some of the genes and gene products that have been used to define the different functions of the zones of the adrenal cortex, mostly using either immunocytochemistry
(shown in normal text) or in situ hybridization (in italics). It is by no means exhaustive, many more components have been listed, notably when cDNA arrays have been used, (e.g., de
Mendonca et al., 2014; Nishimoto et al., 2014; Tyczewska et al., 2014). Plus signs (+) indicate presence, minus signs (−) absence. The number of + signs gives a rough indication of
the abundance of signal under control conditions, i.e., with no special treatment. Naturally all of these values may change, sometimes enormously, if neutral physiological regimes are
perturbed.
*Also reported in glomerulosa, but data not provided.
†
Transcriptome profiling.
to the medulla, and the fasciculata between. How can this
be achieved? As discussed further below, differentiated zonal
function is maintained by systemic factors, including (in
experimental animals at least) angiotensin II, potassium ions
and α-MSH in the glomerulosa, and ACTH in the fasciculata
and reticularis. At the same time these activators are clearly not
the originating stimuli for differentiation since their receptors
are already zonally distributed in order for them to have a
zonally specific response—they therefore reinforce the actions of
existing morphogens. An example of how this can be disturbed
is given by experiments in which the disruption of the tandem
potassium channels TASK1 and TASK3 gives rise to extended
expression of CYP11B2 in the mouse fasciculata, resulting in
aldosterone secretion that is insensitive to sodium intake, though
sensitive to ACTH regulation. This is only true of females,
so this unprecedented chaotically unzoned hypersecretion of
aldosterone is remediable by testosterone treatment (Heitzmann
et al., 2008). In contrast to the action of testosterone, which
tends to restore the normal zonal, i.e., exclusively glomerulosa,
distribution of CYP11B2, inactivation of the Cav2.3 calcium
channel in TASK1−/− mice reduces aldosterone to normal
levels, but leaves CYP11B2 in the fasciculata (El Wakil,
2013).
So, if systemic factors cannot be responsible for localization
of cell type and the organization of the zones, these must instead
depend on factors within the gland. It may be speculated what
such factors might be. We have previously considered these to
be of three types, morphogens or paracrine agents produced
within the gland, growth factors that essentially amplify the
morphogenic signal, and transcription factors (Vinson and Ho,
1998; Vinson, 2003). In essence this is illustrated by the action of
shh in upregulating Gli1, or the Wnt/catenin systems, described
more fully below.
The concept that morphogens, secreted by a fixed source,
diffuse along a concentration gradient to inform more or less
remote cells of their position, and trigger appropriate responses,
is sometimes difficult to envisage, because of the randomness of
diffusion, and its susceptibility to local variation due for example
to tissue inhomogeneity (Lander, 2013), and, in the case of
the adrenal, also because of the relatively massive centripetal
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blood flow (Vinson et al., 1985b; Vinson and Hinson, 1992). The
actions of morphogen gradients have been most widely studied
in the context of limb development and regeneration in mice
and other vertebrates. In mice, for example, bone morphogenetic
proteins, BMPs, which are closely related to the TGF family,
stimulate local growth and regeneration (Urist, 1965; Reddi,
1998; Bandyopadhyay et al., 2006; Tsuji et al., 2006; Yu et al.,
2012) and have been primarily recognized for their roles in
stimulating chondrogenesis and osteogenesis. However, they are
also important in other tissues including the prostate (Thomas
et al., 1998) breast and prostate cancer (Buijs et al., 2010),
and in the pituitary and other components of the reproductive
system (Shimasaki et al., 2004). Here wnt and shh signaling
is crucial, as in the early development of the adrenal (below).
In the limb, induction of shh is brought about by retinoic
acid, which generates positional information at various stages in
development (Tickle, 2006). This is achieved with a robustness
that is remarkable, given the inherent variation in retinoic acid
availability, depending as it does on dietary sources. But retinoic
acid gradients may not depend solely on release and diffusion,
but additionally on sites of degradation, as in the zebrafish brain
(White et al., 2007; Schilling et al., 2012). It is possible that this
applies to other morphogens, which could be critical when not
only morphogen concentration but the duration of target cell
exposure is critical, as in the mouse limb response to shh (Tickle,
2006). Crucially, it is thought that sharp boundaries between
different cell types, such as found in the adrenal cortex, can
still be achieved in the presence of a fluctuating and shallow
morphogen gradient, by means of various mechanisms that
depend in part on cell plasticity and in part on intercellular
signaling. In other systems, these may include for example the
retinoic acid-sensitive autoactivating genes Krox 20 and Hoxb1
that are mutually inhibitory in the zebrafish hindbrain (Zhang
et al., 2012). Other mechanisms of noise-induced switching have
been described (Schilling et al., 2012). Nevertheless, interfering
with gap junctions affects positional clarity (Tickle, 2006), so
direct cell-cell signaling is also involved (Lander, 2013).
With regard to the adrenal, it is clear that the same
morphogens may play a role as in vertebrate limb regeneration,
notably Wnt, Shh and BMPs. BMPs are expressed in all zones
of the human adrenal cortex, but particularly the glomerulosa
(see Table 2). Additionally, in H295R cells, BMP4 suppresses
CYP17 RNA and protein, andDHEA secretion (Rege et al., 2015).
In contrast, overexpression of the transcription factor DACH1
activates TGFβ and canonical Wnt signaling pathways, thereby
suppressing CYP11B2 and aldosterone secretion (Zhou et al.,
2015). Considerable advances in recent years have highlighted the
particular importance of the Wnt/catenin system (MacDonald
et al., 2009). Secreted Wnt glycoproteins bind to GPCRs of
the frizzled family, bringing about increased cell content of
the coactivator β-catenin, now known to be essential for
the differentiation of SF1 positive adrenocortical cells from
the adrenal capsule, and for their proliferation (Kim et al.,
2008, 2009). The Wnt/catenin signaling system is involved in
adrenocortical development in other ways also, by interaction
with the nuclear receptor Dax1 and inhibin, both of which
modulate adrenal/gonadal selection. Dax1is induced by SF1, but
inhibits SF1 stimulated gene transcription (Ito et al., 1997; Yu
et al., 1998). DAX1 is prominent in the subcapsular region
in the mouse adrenal (but completely absent from the X-
zone) (Mukai et al., 2002), together with β-catenin (Pihlajoki
et al., 2015). Inhibin-α, which suppresses gonadal phenotype, is
induced by SF1 and β-catenin (Gummow et al., 2003). The overall
outcome of these effects in combination, is both to establish the
adrenocortical fate of the subcapsular cells, while maintaining
their further developmental plasticity (Wood and Hammer,
2010; Simon and Hammer, 2012). This, in effect, defines the
glomerulosa (Berthon et al., 2012). SF1 is absolutely required for
the development of the gland, and for the cell redifferentiation
associated with centripetal migration (Freedman et al., 2013).
The search for stimulators of migration has however so far
produced meager results. It is possible that the extracellular
matrixmay be involved: in bovine adrenal cells, laminin secretion
is regulated by ACTH, and, in Boyden chamber experiments,
laminin acted as a chemoattractant in promoting adrenal cell
migration. However, the distribution of laminin is uniform
throughout the cortex, and therefore seems unlikely to promote
adrenocortical cell cellular migration (Pellerin et al., 1997).
Other extracellular matrix proteins, including fibronectin and
collagens I and IV, have been shown to affect steroidogenic
enzyme expression in rat adrenal cells in culture, and in particular
to modulate basal and ACTH stimulated steroid secretion
(Otis et al., 2007). Additionally, rat glomerulosa cells secrete
fibronectin, which promotes proliferation, while angiotensin II
interferes with this process at the level of integrin binding, thus
inhibiting proliferation while enhancing steroidogenesis (Otis
et al., 2008).
Equally, how the inward migration of cells is achieved
while the position of the zones relative to each other remains
constant also continues to be a matter of some mystery.
It is possible to speculate that various mechanisms might
play a role. It is entirely possible that structures within the
gland external to the adrenocortical cells themselves provide
positional information. Such structures could include the neural
network or elements of the vasculature, which though not
necessarily visible in conventional microscopy are nevertheless
important components both of which affect adrenocortical
function (Figure 4; Vinson andHinson, 1992; Vinson et al., 1994)
and may be independent of ACTH (Bocian-Sobkowska et al.,
1997). Alternatively, the relative positions of the capsule, external
to the cortex, and of the inner medulla might suggest that a
morphogenetic landscape could be generated by signals from
these two poles. Certainly medullary products can affect inner
cortical function (Ehrhart-Bornstein et al., 2000; Haidan et al.,
2000). Or, another possibility is that positional information is
provided by the adrenocortical cells themselves. Cortical cells,
arranged as they are in cords traversing the cortex, themselves
provide a polarity, indeed each cell may have an apical and
a basal pole. Clearly this is true at least of some of them:
cells of the outermost glomerulosa layer (which express both
CYP11B2, AT1R, and MC5R) about the capsule at one pole, and
other, perhaps less differentiated cells at the base. The innermost
glomerulosa cells in the ZU abut either true zona intermedia
or outer fasciculata cells, while the innermost reticularis cells
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FIGURE 4 | General arrangement of the vasculature and innervation of
the rat adrenal cortex. Most nerves are located in the capsular (c) and
subcapsular region, with arborization around the vasculature, including
arterioles (a) and around the cells of the glomerulosa (zg). Nerve fibers are rare
in the fasciculata (zf), but some traverse the width of the zone, often
associated with medullary arteries (ma, 6–8 per gland), which specifically
supply the medulla. Most of the blood reaching the medulla passes
centripetally through the sinuses, which, in contrast to the thicker walled
medullary arteries, are bordered by a single layer of very attenuated endothelial
cells (cf. Figure 2). Near the medulla (m) a few short nerve fibers reach the
reticularis (zr) from islets of chromaffin cells (i) in the inner cortex and from the
medulla itself. There is now considerable evidence that products from both
neural tissue and vasculature can affect corticosteroid secretion. They may
also provide positional information for migrating and transforming cortical cells
(see text). Drawing by Bridget Landon. Reproduced with permission from
Vinson et al. (1994).
lie directly adjacent to the medulla in the rat: in other species,
such as the postpubertal male mouse there may be a band of
connective tissue around the medulla. Such cell-cell contact is
known to be important in positional information in other tissues
(Tickle, 2006; Lander, 2013). The Eph/ephrin forward-reverse
signaling system provides a possible mechanism for such cellular
orientation and migration within the zones, and elements of the
system have been demonstrated in the rat adrenal cortex. In
particular, EphA2 is strongly transcribed in the rat glomerulosa,
and responds to the physiological stimuli of a low sodium diet,
captopril, or betamethasone treatment in a manner that suggests
association with cell phenotype (Brennan et al., 2008).
FUNCTIONAL ZONATION OF THE
ADRENAL CORTEX
A summary of some of the components expressed in the zones
of the rat mouse and human cortex is given in Table 2. The
StandardModel of adrenocortical zonation, as summarized in the
Introduction, interprets functional zonation in terms of steroid
hormone output alone. It is quite evident that in fact many other
adrenocortical cell products are zone specific, and functional
zonation is not just about steroids. Many of these other zonally
organized functions, such as receptors and signaling pathways
that transduce trophic hormone action, can be considered to
complement the steroidogenic function. Others, such as clock
genes, or enzymes metabolizing xenobiotics, may not be quite so
easily accommodated in this way.
Although the same corticosteroids, cortisol, corticosterone,
and aldosterone (though not usually all three) appear throughout
the non-mammalian vertebrates, functional zonation of the
adrenal cortex is a universal feature in mammals alone. While
the appearance of the zones in different mammalian species
may vary, aspects of their function do not. Thus, it is clear that
the CYP11B2 catalyzed production of aldosterone is invariably
limited to a population of cells in the zona glomerulosa, and
CYP11B1 generates cortisol (or corticosterone in rats, mice,
and some other species) predominantly in the fasciculata, and
to a lesser extent, in the reticularis. Though this is consistent
with the Standard Model, it is nevertheless now clear that some
qualification is required.
The qualification arises because the extent of de novo
steroidogenesis that can be unequivocally associated with each
zone is limited. The human adrenal, for example, is complex.
Here the well-defined CYP11B2-expressing glomerulosa seen
in young individuals gives way in advancing years to a sparse
glomerulosa generally confined to scattered islets (Neville and
O’Hare, 1981; Aiba and Fujibayashi, 2011), interspersed by
cells that may be analogous to those of the rat ZU [and are
called the “progenitor zone” by Aiba and Fujibayashi (2011)],
but which express 3β-HSD. Later, CYP11B2 expressing cell
clusters (APCC) develop at the glomerulosa/fasciculata border,
and extend into the fasciculata (Aiba and Fujibayashi, 2011;
Nishimoto et al., 2015): these appear from the age of about 30
years. These additional sites of aldosterone production, arising
as a consequence of somatic mutation of ion channels, are
common in normal subjects, but the authors hypothesize that
they predispose to primary aldosteronism (Nishimoto et al.,
2015).
In the rat zona glomerulosa, starkly, of the steroidogenic
enzymes only CYP11B2 is at all strongly expressed, and that
only in the outermost glomerulosa: other required components
for complete steroidogenesis, including CYP11A and CYP21 are
barely detectable (Table 2), as is StAR according to some authors
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(Peters et al., 1998, 2007), but not others (Lehoux et al., 1998;
Tyczewska et al., 2014). 3β-HSD appears to be present in all zones
in the rat, as it is in the mouse (Table 2) though it is not expressed
in the glomerulosa of the bovine adrenal (Ishimura and Fujita,
1997) while in humans it is relatively sparse in the glomerulosa
according to some authors (Nishimoto et al., 2010), but not
others (Rainey et al., 2002). Guasti et al. (2013a) located CYP11A
in the inner undifferentiated zone (ZU) of the rat adrenal zona
glomerulosa, quite clearly—indeed by definition—not a site of
CYP11B2 expression, which, as noted, is normally confined to
a very few cells in the outer glomerulosa. Notably, this site of
CYP11A expression coincides with an intense signal for MC2R
mRNA, otherwise apparently lacking in the rat glomerulosa
(Gorrigan et al., 2011). The intensity of MC2R mRNA staining
in this region is not inconsistent with the observations of Gallo-
Payet and Escher (1985) who found greater ACTH binding in
the glomerulosa than other zones, but who did not distinguish
between CYP11B2 expressing and non-expressing glomerulosa
cells. Also contrary to expectation, StAR and CYP11A are not
always co-expressed. Thus not only does the inner ZU site of
CYP11A not coincide with CYP11B2, with the caveats above
in mind, it does not here coincide with StAR either: Peters
and colleagues have consistently demonstrated StAR expression
throughout the fasciculata, but, in untreated animals, hardly at all
in any of the morphologically distinct smaller glomerulosa cells
in the rat, including the ZU (Peters et al., 1998, 2007).
SF1 though is very definitely present throughout the adrenal
cortex (Morohashi et al., 1994; Raza et al., 1998). Although SF1
is absolutely required for the development of the gland and its
steroidogenic capacity (Lala et al., 1992; Parker and Schimmer,
1993; Parker et al., 1995; Freedman et al., 2013), its role must be
very different in the cells of the different zones. Thus, although
exposure to high SF1 inhibits CYP11B2 expression (Ye et al.,
2009), the presence of SF1 in the glomerulosa is required not
only for functional CYP11B2, but also for the glomerulosa-
fasciculata cell type transformation that is a feature of adrenal
cell centripetal migration and redifferentiation (Freedman et al.,
2013).
In contrast to the glomerulosa, all fasciculata cells strongly
express all of the enzymes required for glucocorticoid production
enzymes, CYP11A1, CYP21, CYP11B1, 3β-HSD, and StAR,
together with, in human (and other species’) glands, CYP17 as
well. These components are also present in the reticularis though
(with the possible exception of CYP17) in lower abundance.
This then raises the question: how is aldosterone produced
in the rat and human gland, if the entire required suite of
enzymes and StAR are not co-expressed? Twenty years ago,
we suggested that (at least) two cell types are required for
aldosterone synthesis and secretion in the rat adrenal (Vinson
et al., 1995; Vinson, 2004). The evidence for this is primarily
that in the rat the efficient production of aldosterone in vitro
requires an intact gland, and as it is disrupted, from whole
tissue, first to separated zones, then to enzyme dispersed
cells, aldosterone yields in vitro are progressively diminished,
whereas corticosterone output is unchanged, and 18-OH-DOC,
a major product of the fasciculata in the rat (Tait et al., 1970;
Nonaka and Okamoto, 1991; Okamoto and Nonaka, 1992), is
increased (Vinson et al., 1985a). Together with other evidence
this suggested 18-OH-DOCmight be an aldosterone precursor in
this species (Vinson et al., 1992a, 1995; Vinson, 2004). Objections
may be raised on the basis that the hemiketal structure of 18-
OH-DOC is stable, and not easily converted, that the blood
flow is centripetal, hence precluding steroid movement from
inner zone to the glomerulosa, and that conversion of exogenous
precursors is invariably inefficient. However, tracer 18-OH-DOC
is certainly converted to aldosterone by rat glomerulosa tissue,
and is sensitive to sodium status (Fattah et al., 1977). How it could
reach the glomerulosa in vivo remains open to speculation, but
if we accept that shh and wnt diffuse centrifugally (see above),
there seems no reason why other substances should not. Or there
may be cell-cell transport: it is not the proteolytic enzmes used
in cell dispersal methods that diminishes aldosterone output,
but the physical disruption of the capsular tissue (Raven et al.,
1983). Finally, in the rat 18-OH-DOC circulates at concentrations
sufficient to be utilized as substrate (Vinson, 2004).
It is not suggested that the samemechanism would necessarily
operate in any species other than the rat, which seems to be
unique in that 18-OH-DOC is a major product of the fasciculata.
Nevertheless, in this connection it is intriguing that in the human
gland there exist more obvious mechanisms for the transfer of
steroid substrate or other products from the inner zones to the
glomerulosa. First, there are arteriovenous loops which derive
from the cortical arterioles in the capsule region, pass through
the glomerulosa and fasciculata, but then loop back to the outer
cortex to a site near their origin. Secondly, as the adrenal vein
leaves the gland, the cortex is inverted and wraps around the vein
as the cortical cuff, which retains its zonation, (though inverted).
Here the blood supply is from the arteriae comitantes in the wall
of the vein. Drainage from this region is through vessels from the
medulla through the cortex (i.e., from reticularis to the fasciculata
and glomerulosa), thence to the central vein (Figure 5) (Dobbie
and Symington, 1966; Neville and O’Hare, 1981). Finally, in older
subjects, CYP11B2 expressing aldosterone producing cell clusters
project into the fasciculata (Nishimoto et al., 2015), providing the
possibility of much more intimate contact between the different
cell types.
A more specific function for the reticularis has sometimes
seemed to be less clear cut, especially in those species in which
17-hydroxylase (CYP17) is sparse, but in the human, and some
other species, it is the major source of C19 steroids, especially
dehydroepiandrosterone, both as the free steroid and as the
sulfate. This general concept has been strengthened by methods
developed to separate individual cell types, and assess their
steroid output in vitro, and most recently by microdissection and
transcriptome profiling (see Table 2). Notably, these methods
have shown that CYP11A1 (side chain cleavage) and CYP17 (17-
hydroxylase) gene transcripts are similar in the human fasciculata
and reticularis, but Cyt B5A, sulfotransferase SULT2A1, and
17β-HSD (aldo-ketose reductase AKR1C3) are significantly more
prominent in the reticularis (Rainey et al., 2002; Rege et al.,
2014). The combined activity of these components accounts for
the characteristic secretion of large amounts of DHEAS by the
reticularis: Cyt B5 has been recognized as an important regulator
of CYP17, and its presence is required for the efficient side chain
Frontiers in Neuroscience | www.frontiersin.org 11 June 2016 | Volume 10 | Article 238
Vinson Adrenocortical Zonation
FIGURE 5 | General structure of the human adrenal gland showing the cortical cuff. The inward folding adjacent to the central vein results in a doubling of the
cortical thickness and the juxtaposition in this region of the inner zona glomerulosa and the central vein. C, cortex; M, medulla; ZG, zona glomerulosa; ZF, zona
fasciculata; ZR, zona reticularis; CV, central vein. Drawing by B. Landon. Figure reproduced with permission from Vinson and Hinson (1992).
cleavage activity of CYP17, though not for its 17α-hydroxylase
function (Hall, 1991; Lee-Robichaud et al., 1995; Soucy and Luu-
The, 2002). Cyt B5 acts through allosteric action rather than (as
originally thought) provision of the second electron required for
side chain cleavage (Auchus et al., 1998; Akhtar et al., 2005). It is
the heightened secretion of DHEA and DHEAS by the reticularis
that incurs the onset of adrenarche in humans (Belgorosky et al.,
2008).
How then is androstenedione, the second most abundant
androgen secreted by the human adrenal, actually synthesized?
As we now see, in the human gland, the fasciculata cell expresses
3β-HSD, but the reticularis only a trace. On the other hand,
the fasciculata expresses relatively little Cyt B5, required for C21
steroid side chain cleavage, whereas the reticularis expresses a
lot. Perhaps interaction between the cell types, as postulated for
aldosterone biosynthesis above, provides an answer, with transfer
of DHEA from the reticularis to the fasciculata for the final stage
of 3β-HSD catalyzed dehydrogenation/isomerization to give the
14-3-ketone configuration of androstenedione.
Zonation in the adrenal cortex of the mouse is more complex
than the broad divisions into glomerulosa, fasciculata, and
reticularis, usually taken as the mammalian norm, because of the
additional presence of an inner zone, the X-zone, that is only
apparent in the prepubertal animals of both sexes, and in the
nulliparous adult female. It does not appear to be responsive
to ACTH, and it has been suggested that it is supported by
LH (Chester Jones, 1955). It involutes at puberty in the male
mouse, and at first pregnancy in the female leaving a band of
connective tissue between the reticularis and the medulla. Its
involution is exquisitely sensitive to testosterone, and although
from more recent studies it appears that involution precedes the
increase in blood testosterone associated with puberty in themale
(Hershkovitz et al., 2007), involution does not occur in castrates,
and castration of adult males results in the development of a
secondary X-zone lying outside the connective tissue residue
of the original (Chester Jones, 1955, 1957). The function of
the X-zone has remained largely obscure, though it is known
to express 20α-hydroxysteroid dehydrogenase, but not 3β-
hydroxysteroid dehydrogenase, which occurs widely throughout
the rest of the cortex (Hershkovitz et al., 2007). To some
extent the lack of data regarding this zone is compounded by
the wide variation in its appearance, indeed in some inbred
laboratory animals, notably the DDD strain, the extent of X-zone
vacuolation suggests the presence of little functional tissue at all
(Suto, 2012).
Other components that have a clear zonal distribution are
enzymes that are thought to protect the gland against toxic
products associated with a high degree of cytochrome P450
activity. Thus the aldo-keto reductase-like enzyme, AKR1B7
disposes of isocaproic aldehyde, the byproduct of CYP11A1
mediated cholesterol side chain cleavage, and manganese
superoxide dismutase may protect against free radicals arising
from leaky mitochondrial cytochrome P450 activity, Both of
these enzymes are expressed in inner adrenocortical zones (in
mouse and rat respectively) (Sahut-Barnola et al., 2000; Martinez
et al., 2001; Raza et al., 2005), but not in the glomerulosa. In
this context, seladin-1 (DHCR24), highly expressed in human
and rat fasciculata cells, may be involved in oxidative stress
management, and use of a specific seladin-1 inhibitor enhances
ROS formation in response to ACTH (Battista et al., 2009). It
may also be involved in specific regulation of DHEA secretion
(see below).
Themultifunctional protein that we originally called the Inner
Zone Antigen (IZA) because it is present in the rat adrenocortical
fasciculata and reticularis but not glomerulosa (Laird et al.,
1988; Barker et al., 1992) was later identified with the so-called
progesterone receptor membrane component 1 (PGRMC1) (Min
et al., 2004; Cahill, 2007), and is now also designated as the sigma
2 receptor (Xu et al., 2011; Zeng et al., 2016). In the rat adrenal
this protein specifically supports 21-hydroxylation (Laird et al.,
1988; Min et al., 2005). The inner zone distribution of all three
of these components, AKR1B7, MnSOD, IZA/PGRMC1/Sigma2,
Frontiers in Neuroscience | www.frontiersin.org 12 June 2016 | Volume 10 | Article 238
Vinson Adrenocortical Zonation
and their absence from the glomerulosa is entirely consistent with
the view that the glomerulosa is not a significant site of de novo
steroidogenesis.
Another metabolic function of the adrenal has been described
that has a distinct zonal distribution, this is the capacity for
xenobiotic metabolism conferred by CYP2D16, a member of
the CYP2D cytochrome P450 subfamily, in the reticularis of the
guinea pig (Martin and Black, 1983; Black et al., 1989; Jiang et al.,
1996; Yuan et al., 1998, 2001). CYP2D16 increases with age, and
is more abundant in males than in females, there are also strain
differences (Huang et al., 1996). In contrast to CYP17, which is
enhanced, CYP2D16 is diminished by ACTH treatment (Yuan
et al., 1998), as is 21-hydroxylase in the reticularis, but not in the
outer zones (Colby et al., 1992). It is also bimodally distributed
in that it is abundant in the majority of individual animals, but
low in others (Colby et al., 2000). CYP2D isoforms themselves
have 21-hydroxylase activity however, and are responsible for
this function in the rat brain (Kishimoto et al., 2004). Type 5
17β-HSD, another member of the aldo-keto reductase family,
also designated AKR1C3, is prominently transcribed in the
human reticularis (Rege et al., 2014). Its function, presumably,
is the reduction of 17-ketosteroids, such as androstenedione to
testosterone (Nakamura et al., 2009). Conceivably it may also be
protective, perhaps, like CYP2D16, metabolizing xenobiotics or
(like AKR1B7) metabolizing isocaproic aldehyde. Interestingly,
in other cell types, AKR1C3 also suppresses cell differentiation
(Desmond et al., 2003).
Also not directly part of the corticosteroid synthesizing
apparatus are the clock genes, which are zonally distributed,
though quite differently, in rat and mouse adrenals. Thus Per 1,
Per 2, and Bmal 1 are most strongly expressed in the reticularis
in rats, but, together with other clock genes (see Table 2) in
glomerulosa and fasciculata in mice. Their expression depends
on clock time, and is instrumental in maintaining the circadian
rhythm inherent in corticosteroid secretion, in conjunction with
hypothalamic/pituitary input (and in turn its regulation by the
SCN clock system) and SCN regulated autonomic innervation
(Ishida et al., 2005; Chung S. et al., 2011; Leliavski et al., 2015).
The secretion of endogenous ouabain is also zonal, in
that bovine glomerulosa cells secrete several times as much
as fasciculata cells, both under control conditions, and also
when stimulated by angiotensin II or ACTH (Laredo et al.,
1995). The presence of signaling molecules NOV, SCL27A2, and
TSPAN12, not previously associated with adrenal function, and
their differential transcription in the zones of the human adrenal
cortex (Rege et al., 2014; see Table 2) also add to the view that our
understanding of zonation is far from complete.
REGULATION OF ADRENOCORTICAL
ZONATION
Trophic Regulation of Zonal Function
In part, the maintenance of the differentiated cortex follows
the activation of specific signaling pathways. Glomerulosa
steroidogenic function, that is the expression of CYP11B2 and
the final stage of aldosterone synthesis, for example, is induced by
(among other factors) angiotensin II stimulation, via angiotensin
type 1 receptors (ATR1a and b) resulting in the activation of
calcium mediated signaling pathways, whereas the fasciculata,
CYP11B1 expression and cortisol/corticosterone production are
ACTH dependent, modulated by the melanocortin type 2
receptor (MC2R) acting through cAMP formation.
Regulation of the Glomerulosa
Angiotensin II, the potassium ion and ACTH are the most widely
studied regulators of aldosterone secretion and glomerulosa
function. They have both acute effects and longer term trophic
actions.
There is ample evidence that angiotensin II supports
glomerulosa structure and aldosterone secretion in a manner
which parallels that of dietary sodium restriction: this topic has
been reviewed on many occasions, and need not be repeated
here (Mulrow, 1999; Hattangady et al., 2012; Bollag, 2014). The
potassium ion also has direct stimulatory actions, both on acute
secretion of aldosterone (Haning et al., 1970; Aguilera and Catt,
1978), and, longer term, in induction of CYP11B2 (Tremblay
et al., 1992; Yagci et al., 1996). Its action is mediated through
voltage gated calcium channels (Haning et al., 1970; Aguilera and
Catt, 1986; Kenyon et al., 1991) but also may require the presence
of angiotensin II, perhaps generated by the intra-adrenal RAS, as
well (Yamaguchi et al., 1990; Tremblay et al., 1992; Gupta et al.,
1995; Vinson et al., 1998), certainly the actions of angiotensin II
and potassium ions are linked (Shepherd et al., 1991).
ACTH, has long been recognized as an acute stimulator of
aldosterone secretion (Haning et al., 1970; Aguilera and Catt,
1978; Braley et al., 1992; Williams, 2005; Hattangady et al., 2012;
Bollag, 2014). In the rat, this presents an enigma, how is this
achieved?—given what we now know about the distribution
of MC2R and CYP11A expressing cell types, which in the
glomerulosa are seemingly confined to the inner ZU and do
not coincide with CYP11B2 (Gorrigan et al., 2011; Guasti et al.,
2013a). But glomerulosa preparations, such as used by many
authors (Haning et al., 1970; Aguilera and Catt, 1978; Braley et al.,
1992; Williams, 2005) clearly will contain both CYP11B2 and
CYP11A/MC2R-expressing cell types, as well as, usually, some
fasciculata cells as well. This raises the possibility of cell-cell
interaction, developed further below.
Chronically, on the other hand, ACTH does not support
the glomerulosa cell phenotype, but instead downregulates
CYP11B2, induces CYP11B1, and in these and other ways
imposes the fasciculata phenotype instead (Aguilera et al., 1981;
Ho and Vinson, 1993; Ni et al., 1995; Mitani et al., 1996). Though
aldosterone secretion is also sensitive to ACTH stimulation
(Hattangady et al., 2012), MC2R inactivated mice have normal
glomerulosa, but greatly involuted fasciculata (Chida et al., 2007),
whereas POMC knock-out may disrupt the adrenal entirely (see
below). This may be attributed to the additional loss of α-MSH
which in rats acts specifically on the glomerulosa in which MC5R
abound (van der Kraan et al., 1998; Liakos et al., 2000): α-
MSH acting on MC5R is 10 times more potent than ACTH
(1-39), and 100 times more than γ-MSH in stimulating cAMP
(Griffon et al., 1994). There is however a problem in that α-
MSH stimulation of aldosterone production by the rat adrenal
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is not convincingly linked to cAMP, which is only stimulated at
high α-MSH concentrations, whereas IP3 and PKC pathways are
activated at lower levels (Kapas et al., 1992, 1994); others have
suggested that a further MSH receptor remains to be discovered
(Bicknell et al., 2000). In hypophysectomised rats, α-MSH, not
ACTH is the POMC product that restores aldosterone secretion
and its response to sodium depletion (Shenker et al., 1985), cf.
(Vinson et al., 1980; Costa et al., 2011).
Downstream of the increased intracellular calcium evoked by
potassium or angiotensin II, the orphan nuclear receptors Nurr1
and NFGFIB are both implicated in CYP11B2 expression, which
also responds to COUP, SF-1 and CREB through promoter sites
(Bassett et al., 2004b,c). NFGFIB, somewhat more widespread
through the (human) cortex than Nurr1 (see Table 2), also
mediates the expression of 3β-HSD2, which converts the 15,3β-
hydroxy configuration of 17α-hydroxypregnenolone or DHEA
to the corresponding 14,3-ketones (Bassett et al., 2004a,d).
Angiotensin II also inhibits CYP17 expression, via PKC and
src-kinase mediated pathways.
Many other factors have been found to modulate aldosterone
secretion, at least under experimental conditions, these include
particularly the neurotransmitters (Torda et al., 1988; Janossy
et al., 1998; Vinson, 2003; Whitworth et al., 2003) cytokines,
which are also produced within the gland (Judd and MacLeod,
1992; Ehrhart-Bornstein et al., 1998; Judd, 1998; Call et al.,
2000), vascular products, including endothelins, nitric oxide, and
adrenomedullin (Hinson and Kapas, 1998; Delarue et al., 2004),
and adipokines (Willenberg et al., 2008).
Actions of ACTH on Adrenal Proliferation
and Zonation
The earliest observations on the effects of hypophysectomy and
ACTH treatment on adrenal form and function, showing the
absolute dependence of the inner adrenocortical zones, but not
the glomerulosa, on an intact functioning pituitary, was borne
out by later experiments using specific gene knockout methods.
First, the elimination of POMC products, including ACTH, was
shown to prevent the complete development of the adrenal
gland. In one study, the adrenals of POMC−/− mice were
not macroscopically discernable, and both corticosterone and
aldosterone were undetectable (Yaswen et al., 1999). However, in
another report, although both fasciculata and reticularis/X-zone
were greatly reduced in the mutant animals, the glomerulosa was
relatively unaffected, and this was reflected in the milder effect
on circulating aldosterone, while corticosterone was virtually
eliminated (Coll et al., 2004). The administration of ACTH
restored both circulating corticosterone (but not aldosterone)
and adrenocortical structure to normal (Coll et al., 2004). In a
later study, MC2R−/− animals were also shown to have normal
glomerulosa structure, but greatly reduced inner adrenocortical
zones, combined with undetectable plasma corticosterone while
aldosterone was reduced by two thirds (Chida et al., 2007). These
effects, of POMC [at least in the (Coll et al., 2004) study] and
MC2R knockout, appear accurately to reproduce the actions
of hypophysectomy (Chester Jones, 1957; Deane, 1962; Vinson,
2003). It is curious that the rat adrenal also expresses AgRP, an
α-MSH antagonist (Yang et al., 1999) but only in the fasciculata
and reticularis, and not the glomerulosa (Bicknell et al., 2000):
in the mouse, the agouti locus is associated with X-zone, but not
reticularis, morphology (Tanaka et al., 1994, 2006).
Other studies suggest that even within the zona fasciculata
different areas may respond differently to chronic stress, which
induced hyperplasia in the outer fasciculata, and hypertrophy
in the inner fasciculata, while glomerulosa cell size was reduced
(Ulrich-Lai et al., 2006).
Peptides derived from pro-γ-MSH, a 16kD fragment from the
N-terminus of the POMCmolecule secreted by the pituitary, that
do not contain the γ-MSH sequence are thought to have a role
in stimulating adrenocortical proliferation (Estivariz et al., 1982,
1988) and POMC 1-28 in particular has been shown to have
this activity. An adrenal serine protease, designated AsP, which
is thought to generate mitogenic peptides from pro-γ-MSH at
the adrenocortical cell surface, has been characterized (Bicknell
et al., 2001; Bicknell, 2003). Support for this concept has been
provided by some subsequent authors, who found that POMC
1-28 stimulated adrenocortical proliferation in dexamethasone
or hypophysectomised rats, though primarily in the glomerulosa
(Torres et al., 2010; Mendonca and Lotfi, 2011), but others
found it had no effect on adrenal growth in POMC−/− mice,
although there was a good response to ACTH (Coll et al., 2006).
In contrast, in vitro, rat POMC 1-28 stimulated proliferation
in cultured rat glomerulosa and fasciculata/reticularis cells, but
ACTH was inhibitory (Mattos et al., 2011). The discrepancy
between the stimulatory actions of ACTH on adrenal cell
proliferation in vivo and its inhibitory actions in vitro is difficult
to resolve. It is possible that other tissue components, such as the
vasculature (Figure 4), absent from cell cultures, are required for
the proliferative actions of ACTH in vivo (Thomas et al., 2004).
Although dependence on ACTH is paramount, other
factors are known to modulate fasciculata cell secretory
activity, including cytokines, which are differentially produced
throughout the cortex, and have specific actions on individual cell
types (Spangelo et al., 1995; Judd, 1998; Koldzic-Zivanovic et al.,
2006; Woods and Judd, 2008), and neurotransmitters (Ehrhart-
Bornstein et al., 2000). The possibility of medullary, neural and
vascular regulation of cortical function is emphasized by the
intimate relationship between these adrenal gland components
(Figure 4).
Regulation of the Reticularis
The control of adrenal androgen secretion is problematic, in that
although supported by ACTH, secretion of androstenedione and
DHEA is dissociated from cortisol under some conditions, and
particularly during adrenarche which has led some authors to
postulate additional pituitary or other factors (McKenna et al.,
1997; l’Allemand and Biason-Lauber, 2000), and, more recently,
melatonin was found to stimulate DHEA release from cultured
adrenals of the solitary hamster Phodopus sungorus (Rendon
et al., 2015). However, the factors causing the increase of adrenal
androgen secretion during adrenarche are largely unknown, as
are those causing the later decline, or adrenopause (Dharia and
Parker, 2004; Bird, 2012) leading some authors to postulate the
importance of intra-adrenal factors; these could include growth
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factors (l’Allemand and Biason-Lauber, 2000), cytokines or even
steroids. Cortisol stimulates DHEA secretion in H295R cells
by inhibiting 3β-HSD (Topor et al., 2011), DHEA modulates
chromaffin cell proliferation and differentiation (Chung K. F.
et al., 2011) and LH receptors are present in human fasciculata
and reticularis, albeit at a low level (Pabon et al., 1996; Rao,
2010). However, another provocative finding in this regard is
that inhibition of seladin-1, which is strongly expressed in the
fasciculata and reticularis of the human adrenal, specifically
inhibits the ACTH induced secretion of DHEA in human adrenal
cells, while having no effect on cortisol output (Battista et al.,
2009). This awaits physiological interpretation.
THE SIGNIFICANCE OF
ADRENOCORTICAL ZONATION—HOW
DOES THE STANDARD MODEL STAND
UP?
That adrenocortical cells arise in the capsular or subcapsular
region of the gland and migrate inwards is now virtually
unchallenged. That proliferation can occur throughout the gland
is also clear, but does not affect the main thesis, even given there
appear to be exceptional situations in which migration may be
reversed.
It is also clear that the distribution of enzymes and
other components between the zones show sharp phenotypic
differences between the glomerulosa and the fasciculata, and
slightly less sharp differences between the fasciculata and the
reticularis, hence the inwardly migrating cells undergo more
or less profound phenotypic changes in their lifespan. What
remains unclear is how this is achieved, although recent advances
in our understanding of the role of morphogens such as wnt
and shh give some powerful guides: these go a long way to
explaining how the glomerulosa becomes differentiated from
the capsule. Remaining to be determined is how the fasciculata
becomes distinct from the glomerulosa, or the reticularis from
the fasciculata. What morphogens are involved here?
As well as the speculation that they could conceivably
be products of neural or vascular components of the gland
(Figure 4), one school of thought holds that it could be the steroid
products themselves. From in vitro studies, and on the basis that
there may be a gradient of steroids from the outer to the inner
part of the cortex, Hornsby and colleagues postulated that this
results in high concentrations of steroids in the inner zones,
which, by acting as pseudosubstrates, could directly compromise
cytochrome P450 structure and function, in this way perhaps
inhibiting hydroxylase activity in the reticularis, for example
(Hornsby, 1987). Though this is contrary to the usual concept
of morphogen diffusion which posits a decrease in concentration
with distance from the source, it acquires new life, and a new
mechanism, with the characterization of GR in the human
adrenal cortex, particularly in the reticularis (Paust et al., 2006).
That the individual zones have defined steroidogenic roles is
clear. Whether they are completely autonomous is less so. Rather,
because of the paucity of other steroidogenic enzymes in the
CYP11B2 expressing cells of the glomerulosa, it is arguable that
the substrate for CYP11B2 must come from the fasciculata, and
the different ways this could occur are via cell-cell contact, or by
uptake from the general circulation, as presumably is the case
for extra-adrenal CYP11B2 thought by some to be expressed in
the vasculature and other tissues (Hatakeyama et al., 1996; Taves
et al., 2011; though not by others, MacKenzie et al., 2012) or by
diffusion. Similarly, the production of androstenedione by the
human gland would seem, on the basis of the zonal distribution
of enzymes possibly to be a reflection of the availability of DHEA
from the reticularis to 3β-HSD in the fasciculata.
If that is the case, then the regulation of these secretory
products must also reflect co-operation between zones. Given the
distribution of mRNA coding for MC2R in the rat adrenal, in
the inner ZU, and fasciculata/reticularis but not in the CYP11B2
region of the glomerulosa (Gorrigan et al., 2011), the well-
recognized stimulation of aldosterone secretion by ACTH is
otherwise difficult to explain. Of course it is still possible that
it is the MC5R in the glomerulosa to which ACTH binds. The
actions of angiotensin II and α-MSH on aldosterone secretion in
the rat are equally difficult to understand, because the appropriate
receptors, AT1R and MC5R respectively, do not appear to
coincide with CYP11A1, thus cholesterol side chain cleavage, the
recognized site in the pathway for stimulation of steroid hormone
secretion, seemingly cannot be directly affected by these agents
(Figure 3).
Taken together, all this evidence seems to suggest it may
be mistaken to think of the adrenal cortex, or even the whole
adrenal gland, as simply a collection of different types of cells,
each independently performing its role in isolation. Rather we
should think of these different cell types as acting in concert. We
have understood for some time now that there are intraadrenal
mechanisms that modify and refine the signals from the systemic
regulators. These comprise medullary products, cytokines, the
adrenal renal-angiotensin system, among others, and have been
reviewed elsewhere (Ehrhart-Bornstein et al., 1998). Extending
this has been conceptually problematic in view of the apparently
confounding effect of the blood flow through the gland, which
would seemingly limit the action any cell might have on other
than its closest neighbors by secreted products.
We now know that secreted products from adrenocortical cells
can indeed pervade the gland through diffusion, and this has been
demonstrated by the wnt-catenin and shh-Gli signaling systems.
So if it is possible for these products then there is no reason why it
cannot be the case for others, including perhaps catecholamines,
cytokines, and the steroids themselves. This may give a partial
explanation for the architecture of the gland, one of the problems
posed at the start of this article—why are the zones arranged
as concentric spheres? One answer may be that this has the
potential to maximize the likelihood of diffused products arriving
at their targets. If we take as an example the secretion of shh
from its origin in the ZU, random walk diffusion to its target in
the inner capsule is better achieved when the capsule completely
envelops the glomerulosa than it would be if the system were
more open, or composed of sheets, like a mesentery or secretory
epithelium.
In addition, there is absolutely no reason to suppose the
steroids themselves do not move between the zones, as substrates
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or modifiers. How else can we explain how aldosterone or
androstenedione are synthesized? And, given that MC2R and
CYP11A1 are expressed in the ZU and fasciculata, but not the
CYP11B2 expressing cells of the rat glomerulosa, how else can
we explain how ACTH has its undoubted action on aldosterone
secretion, other than by the enhanced provision of steroid
substrates from the ZU or the fasciculata to the CYP11B2 cells
in the glomerulosa?
Like the human body itself, the function of the adrenal gland
is an integrated whole, much greater than the sum of its parts. We
should aim to think of it that way.
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